Research programme: histamine H1 receptor modulators - Eli Lilly

Drug Profile

Research programme: histamine H1 receptor modulators - Eli Lilly

Alternative Names: HY-10427

Latest Information Update: 21 Apr 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eli Lilly
  • Class Dibenzoxazepines; Small molecules
  • Mechanism of Action Histamine H1 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Insomnia

Most Recent Events

  • 21 Apr 2009 No development reported - Preclinical for Insomnia in USA (unspecified route)
  • 03 Apr 2007 Hypnion has been acquired and merged into Eli Lilly
  • 19 Dec 2005 Preclinical trials in Insomnia in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top